Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
PNAS Nexus|January 27, 2023
Stochastic activation of a family of TetR type transcriptional regulators controls phenotypic heterogeneity in <i>Acinetobacter baumannii</i>María Pérez-Varela, Aimee R P Tierney, Emma Dawson, et al.Plos One|April 19, 2012
Longitudinal analysis of the temporal evolution of Acinetobacter baumannii strains in Ohio, USA, by using rapid automated typing methodsBrooke K Decker, Federico Perez, Andrea M Hujer, et al.Journal of Clinical Microbiology|March 20, 2009
Rapid determination of quinolone resistance in Acinetobacter sppKristine M Hujer, Andrea M Hujer, Andrea Endimiani, et al.Npj Antimicrobials and Resistance|July 27, 2025
Inter- and intra-bacterial strain diversity remains the "elephant in the (living) room"Adam Valcek, Carsten Kröger, Rubén de Dios, et al.Antimicrobial Agents and Chemotherapy|January 28, 2025
Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030Laura J Rojas, Travis B Nielsen, Paul Pantapalangkoor, et al.Antimicrobial Agents and Chemotherapy|January 5, 2023
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural AnalysesTahani A Alsenani, María Margarita Rodríguez, Barbara Ghiglione, et al.Antimicrobial Agents and Chemotherapy|July 30, 2014
Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast OhioFederico Perez, Andrea M Hujer, Steven H Marshall, et al.Antibiotics (Basel, Switzerland)|April 28, 2023
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in <i>Acinetobacter baumannii</i>Maria Luisa Introvigne, Trevor J Beardsley, Micah C Fernando, et al.Mbio|March 14, 2019
Targeting Multidrug-Resistant <i>Acinetobacter</i> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic AgentMelissa D Barnes, Vijay Kumar, Christopher R Bethel, et al.Antimicrobial Agents and Chemotherapy|September 27, 2006
Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical CenterKristine M Hujer, Andrea M Hujer, Edward A Hulten, et al.Pageof 8